IS6716A - Methods for producing cilostasol - Google Patents

Methods for producing cilostasol

Info

Publication number
IS6716A
IS6716A IS6716A IS6716A IS6716A IS 6716 A IS6716 A IS 6716A IS 6716 A IS6716 A IS 6716A IS 6716 A IS6716 A IS 6716A IS 6716 A IS6716 A IS 6716A
Authority
IS
Iceland
Prior art keywords
cilostasol
producing
methods
producing cilostasol
Prior art date
Application number
IS6716A
Other languages
Icelandic (is)
Inventor
Mendelovichi Marioara
Finkelstein Nina
Pilarksi Gideon
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of IS6716A publication Critical patent/IS6716A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
IS6716A 2000-08-14 2003-02-13 Methods for producing cilostasol IS6716A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22536200P 2000-08-14 2000-08-14
PCT/US2001/025398 WO2002014283A1 (en) 2000-08-14 2001-08-14 Processes for preparing cilostazol

Publications (1)

Publication Number Publication Date
IS6716A true IS6716A (en) 2003-02-13

Family

ID=22844569

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6716A IS6716A (en) 2000-08-14 2003-02-13 Methods for producing cilostasol

Country Status (17)

Country Link
EP (1) EP1311485A4 (en)
JP (2) JP3845059B2 (en)
KR (1) KR20030024865A (en)
CN (1) CN1469864A (en)
AU (1) AU2001284887A1 (en)
CA (1) CA2419181A1 (en)
CZ (1) CZ2003667A3 (en)
HK (1) HK1053116A1 (en)
HU (1) HUP0302688A2 (en)
IL (1) IL154458A0 (en)
IS (1) IS6716A (en)
MX (1) MXPA03001470A (en)
NO (1) NO20030699L (en)
NZ (1) NZ524363A (en)
PL (1) PL365672A1 (en)
SK (1) SK2992003A3 (en)
WO (1) WO2002014283A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045547A1 (en) 2001-05-02 2003-03-06 Shinji Aki Process for producing carbostyril derivatives
US7399864B2 (en) 2001-05-02 2008-07-15 Otsuka Pharmaceutical Co., Ltd. Process for producing carbostyril derivatives
US20050101631A1 (en) 2002-08-01 2005-05-12 Otsuka Pharmaceuticals Company Process for producing carbostyril derivatives
EP1489080B1 (en) 2002-09-10 2011-01-26 Otsuka Pharmaceutical Co., Ltd. Process for producing cilostazol
WO2006001846A1 (en) * 2004-02-05 2006-01-05 Teva Pharmaceutical Industries Ltd. Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril
KR100633232B1 (en) * 2004-08-25 2006-10-11 주식회사유한양행 Novel 6- [4- (1-cyclohexyl-1H-tetrazol-5-yl) butoxy] -3,4-dihydro-2 (1H) -quinolinone purification method
US20070270590A1 (en) * 2006-04-20 2007-11-22 Marioara Mendelovici Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone
TW200848041A (en) 2007-03-30 2008-12-16 Otsuka Pharma Co Ltd A medicament for treating schizophrenia comprising cilostazol
ES2401914T3 (en) 2007-04-25 2013-04-25 Concert Pharmaceuticals Inc. Cilostazol analogues
CN101434598B (en) * 2008-12-19 2012-11-07 重庆康乐制药有限公司 Preparation of cilostazol
CN102086190B (en) * 2011-01-28 2013-07-10 海南美兰史克制药有限公司 Cilostazol compound and novel preparation method thereof
CN107382970A (en) * 2017-07-26 2017-11-24 浙江金立源药业有限公司 A kind of synthetic method of Cilostazol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5535019A (en) * 1978-09-01 1980-03-11 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
JPH01265051A (en) * 1988-04-14 1989-10-23 Fuji Photo Film Co Ltd Production of diaryloxyalkane

Also Published As

Publication number Publication date
EP1311485A1 (en) 2003-05-21
JP3845059B2 (en) 2006-11-15
NZ524363A (en) 2004-03-26
CZ2003667A3 (en) 2003-08-13
HUP0302688A2 (en) 2003-12-29
JP2004506043A (en) 2004-02-26
CA2419181A1 (en) 2002-02-21
NO20030699D0 (en) 2003-02-13
KR20030024865A (en) 2003-03-26
HK1053116A1 (en) 2003-10-10
EP1311485A4 (en) 2004-05-12
WO2002014283A1 (en) 2002-02-21
JP2005350474A (en) 2005-12-22
MXPA03001470A (en) 2005-06-30
AU2001284887A1 (en) 2002-02-25
PL365672A1 (en) 2005-01-10
SK2992003A3 (en) 2003-10-07
CN1469864A (en) 2004-01-21
NO20030699L (en) 2003-04-10
IL154458A0 (en) 2003-09-17

Similar Documents

Publication Publication Date Title
DK1226127T3 (en) Substituted phenylsulfamoylcarboxamides
DE60126645D1 (en) SULFONAMIDETHER - SUBSTITUTED IMIDAZOCHINOLINE
ATE312098T1 (en) THIAZINOXAZOLIDINONE
DE60114153D1 (en) SUBSTITUTED ARYLPYRAZINE
DE50115520D1 (en) BEAM FORMING METHOD
PL353369A1 (en) Method for producing pure citalopram
PL359825A1 (en) Method for producing citalopram
AR028393A1 (en) SUBSTITUTED IMINOAZIDS
NO20024893D0 (en) Methods for ansamitocin production
NO20030276L (en) Approach
DE10196082T1 (en) FLIP-CHIP-assembly process
DE50112662D1 (en) SUBSTITUTED BENZOYLCYCLOHEXENONE
AR028302A1 (en) SUBSTITUTED FENILURACILOS
DE50100418D1 (en) BREZEL PRODUCTION SYSTEM
IT250181Y1 (en) IMPROVED CASE FOR RIVOLELLA
FI20001655L (en) Crystallization method
ID30126A (en) METHODS FOR PRODUCING SIKLO- (Asp-DPhe-NMeVal-Arg-Gly)
ATE284887T1 (en) THIENOPYRROLIDINONE
ATE474032T1 (en) FISCHER-TROPSCH METHOD
FI4651U1 (en) Well
DE50009641D1 (en) Axialkugellager
FI20001398L (en) Well
FR2817889B1 (en) FORM
ID29728A (en) PROCESS FOR MAKING SUBSTITUTED PIRIDINS
SE0002604D0 (en) synthesis Method